Literature DB >> 25205231

Measuring end-of-life care and outcomes in residential care/assisted living and nursing homes.

Sheryl Zimmerman1, Lauren Cohen2, Jenny T van der Steen3, David Reed4, Mirjam C van Soest-Poortvliet5, Laura C Hanson2, Philip D Sloane6.   

Abstract

CONTEXT: The two primary residential options for older adults who require supportive care are nursing homes and residential care/assisted living. More than one-quarter of all deaths in the U.S. occur in these settings. Although the information available on end of life in long-term care has been growing, the comparative suitability of various measures to guide this work is unknown.
OBJECTIVES: To determine the optimal measures to assess end-of-life care and outcomes in nursing homes and residential care/assisted living.
METHODS: A total of 264 family members of decedents from 118 settings were interviewed and provided data on 11 instruments that have been used in, but not necessarily developed for, long-term care populations; Overall, 20 scales and subscales/indices were evaluated. Measures were compared on their psychometric properties and the extent to which they discriminated among important resident, family, and setting characteristics.
RESULTS: Prioritizing measures that distinguish the assessment of care from the assessment of dying, and secondarily that exhibit an acceptable factor structure, this study recommends two measures of care-the Family Perceptions of Physician-Family Caregiver Communication and the End of Life in Dementia (EOLD)-Satisfaction With Care-and two measures of outcomes-the EOLD-Symptom Management and the EOLD-Comfort Assessment in Dying. An additional measure to assess outcomes is the Mini-Suffering State Examination (MSSE). The care measures and the MSSE are especially valuable as they discriminate between decedents who were and were not transferred immediately before death, an important outcome, and whether the family expected the death, a useful target for intervention.
CONCLUSION: Despite these recommendations, measurement selection should be informed not only on the basis of psychometric properties but also by specific clinical and research needs. The data in this manuscript will help researchers, clinicians, and administrators understand the implications of choosing various measures for their work.
Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Measurement; death; dying; end of life; long-term care; nursing home; residential care/assisted living

Mesh:

Year:  2014        PMID: 25205231     DOI: 10.1016/j.jpainsymman.2014.08.009

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

1.  Prevalence and Predictors of Symptoms in Persons with Advanced Dementia Living in the Community.

Authors:  Kurt Kroenke; Sujuan Gao; Kelly M Mosesso; Susan E Hickman; Laura R Holtz; Alexia M Torke; Nina M Johnson; Greg A Sachs
Journal:  J Palliat Med       Date:  2022-03-29       Impact factor: 2.947

2.  Provider Perspectives on the Influence of Family on Nursing Home Resident Transfers to the Emergency Department: Crises at the End of Life.

Authors:  Caroline Stephens; Elizabeth Halifax; Nhat Bui; Sei J Lee; Charlene Harrington; Janet Shim; Christine Ritchie
Journal:  Curr Gerontol Geriatr Res       Date:  2015-08-24

3.  Effects of facilitated family case conferencing for advanced dementia: A cluster randomised clinical trial.

Authors:  Meera Agar; Tim Luckett; Georgina Luscombe; Jane Phillips; Elizabeth Beattie; Dimity Pond; Geoffrey Mitchell; Patricia M Davidson; Janet Cook; Deborah Brooks; Jennifer Houltram; Stephen Goodall; Lynnette Chenoweth
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

4.  A systematic review and critical appraisal of quality indicators to assess optimal palliative care for older people with dementia.

Authors:  Sarah Amador; Elizabeth L Sampson; Claire Goodman; Louise Robinson
Journal:  Palliat Med       Date:  2019-03-11       Impact factor: 4.762

5.  End of life care for long-term care residents with dementia, chronic illness and cancer: prospective staff survey.

Authors:  Michal Boyd; Rosemary Frey; Deborah Balmer; Jackie Robinson; Heather McLeod; Susan Foster; Julia Slark; Merryn Gott
Journal:  BMC Geriatr       Date:  2019-05-22       Impact factor: 3.921

6.  Revisiting the Role of Physicians in Assisted Living and Residential Care Settings.

Authors:  Sarah Dys; Lindsey Smith; Ozcan Tunalilar; Paula Carder
Journal:  Gerontol Geriatr Med       Date:  2020-12-10

7.  No difference in effects of 'PACE steps to success' palliative care program for nursing home residents with and without dementia: a pre-planned subgroup analysis of the seven-country PACE trial.

Authors:  Rose Miranda; Tinne Smets; Nele Van Den Noortgate; Jenny T van der Steen; Luc Deliens; Sheila Payne; Katarzyna Szczerbińska; Sophie Pautex; Liesbeth Van Humbeeck; Giovanni Gambassi; Marika Kylänen; Lieve Van den Block
Journal:  BMC Palliat Care       Date:  2021-03-07       Impact factor: 3.234

Review 8.  Advance care planning in dementia: recommendations for healthcare professionals.

Authors:  Ruth Piers; Gwenda Albers; Joni Gilissen; Jan De Lepeleire; Jan Steyaert; Wouter Van Mechelen; Els Steeman; Let Dillen; Paul Vanden Berghe; Lieve Van den Block
Journal:  BMC Palliat Care       Date:  2018-06-21       Impact factor: 3.234

9.  Tools Measuring Quality of Death, Dying, and Care, Completed after Death: Systematic Review of Psychometric Properties.

Authors:  Nuriye Kupeli; Bridget Candy; Gabrielle Tamura-Rose; Guy Schofield; Natalie Webber; Stephanie E Hicks; Theodore Floyd; Bella Vivat; Elizabeth L Sampson; Patrick Stone; Trefor Aspden
Journal:  Patient       Date:  2019-04       Impact factor: 3.883

10.  Cultural Adaptation and Validation of the Quality of Dying in Long-Term Care Scale (QoD-LTC) for Spanish Nursing Homes.

Authors:  Daniel Puente-Fernández; Rosel Jimeno-Ucles; Emilio Mota-Romero; Concepción Roldán; Katherine Froggatt; Rafael Montoya-Juárez
Journal:  Int J Environ Res Public Health       Date:  2021-05-16       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.